Cargando…
Non-Utilization of Cryopreserved Stem Cell Products from Unrelated Donors during the COVID-19 Pandemic
Autores principales: | Buk, Deborah, Mengling, Thilo, Seitz, Susanne, Platz, Alexander, Schmidt, Alexander H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Transplantation and Cellular. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202758/ http://dx.doi.org/10.1016/S2666-6367(21)00306-7 |
Ejemplares similares
-
Unrelated Donor Usage for Allogeneic HCT in Canada during the First 6 Months of the COVID-19 Pandemic: A Canadian Blood Services Stem Cell Registry Analysis
por: Allan, David, et al.
Publicado: (2021) -
A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the Covid‐19 pandemic
por: Schmidt, Alexander H., et al.
Publicado: (2021) -
Cryopreservation for All Is No Option in Unrelated Stem Cell Transplantation. Comment on Dholaria B, et al. Securing the Graft During Pandemic: Are We Ready for Cryopreservation for All? Biol Blood Marrow Transplant. 2020;26:e145-e146.
por: Schmidt, Alexander H., et al.
Publicado: (2020) -
Novel use of percutaneous thrombosuction to rescue the early thrombosis of the conduit vein graft after living donor liver transplantation
por: Jeng, Kuo-Shyang, et al.
Publicado: (2018) -
Cryopreservation of Allogeneic Hematopoietic Cell Grafts Did Not Adversely Impact Early Post-Transplant Survival during the First Six Months of the COVID-19 Pandemic
por: Devine, Steven M., et al.
Publicado: (2022)